Related Experiment Video
Updated: Feb 20, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary
Jin-Ming Cen1, Jie Cheng2, Qing-Yuan Xiong3
1Department of Cardiology, Foshan Municipal First People's Hospital, Foshan, Guangdong 528000, China.
Insights
Plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are elevated in coronary heart disease (CHD) patients. Higher Lp-PLA2 concentrations correlate with increased CHD severity and may synergize with hs-CRP in atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Inflammation Research
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Lipoprotein-associated phospholipase A2 (Lp-PLA2) is implicated in atherosclerotic plaque development.
- Understanding biomarkers for CHD severity is crucial for risk stratification.
Purpose of the Study:
- To investigate the correlation between plasma Lp-PLA2 levels and coronary heart disease (CHD).
- To compare plasma Lp-PLA2 concentrations across different CHD subtypes.
- To explore the relationship between Lp-PLA2 and other cardiovascular risk factors.
Main Methods:
- Blood samples were collected from 56 CHD patients and 34 healthy controls.
- Plasma Lp-PLA2 concentrations were measured.
- Levels of total cholesterol, triglycerides, apolipoproteins, HDL-c, LDL-c, Lp(a), glucose, and hs-CRP were determined.
Main Results:
- Plasma Lp-PLA2 was significantly higher in all CHD subgroups compared to controls (P < 0.05).
- Lp-PLA2 levels were highest in acute myocardial infarction (AMI) patients, followed by unstable angina pectoris (UAP), and then stable angina pectoris (SAP) (P < 0.05).
- Plasma Lp-PLA2 showed a positive correlation with high-sensitivity C-reactive protein (hs-CRP) (r = 0.493, P < 0.05) but not with other tested lipid parameters.
Conclusions:
- Elevated plasma Lp-PLA2 is associated with CHD.
- Plasma Lp-PLA2 concentrations vary significantly across different CHD severity levels.
- Synergistic action between Lp-PLA2 and hs-CRP may contribute to the inflammatory response in atherosclerosis.
Objective:
This study explores the correlation between plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) and coronary heart disease (CHD) by comparing the level of plasma Lp-PLA2 in the plasma of patients with different types of CHD.
Methods:
Blood samples were collected from 56 patients diagnosed with CHD by the Department of Cardiology of the First People's Hospital of Foshan and 34 healthy subjects from February 2013 to January 2014. We measured the concentration of plasma Lp-PLA2 and determined the levels of total cholesterol (Tch), triglyceride (TG), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), high density lipoprotein-cholesterol (HDL-c), low density lipoprotein-cholesterol (LDL-c), lipoprotein a (Lp(a)), glucose (Glu), and high-sensitivity C-reactive protein (hs-CRP). The concentration of plasma Lp-PLA2 in the healthy control group and each subgroup of CHD patients were compared and analyzed for correlations of plasma Lp-PLA2 between the patients in different CHD subgroups and several laboratory indicators.
Results:
The concentration of plasma Lp-PLA2 in each subgroup of CHD was significantly higher than in the control group (P < 0.05). The concentration of Lp-PLA2 in the unstable angina pectoris (UAP) group and acute myocardial infarction (AMI) group were significantly higher than in the stable angina pectoris (SAP) group (P < 0.05), and the concentration of plasma Lp-PLA2 in the AMI group was significantly higher than in the UAP group (P < 0.05). The concentration of plasma Lp-PLA2 in the CHD group merely showed a positive correlation (r = 0.493, P < 0.05) with the hs-CRP group, but the levels of Tch, TG, Apo-A1, Apo-B, HDL-c, LDL-c, Lp(a) and Glu did not.
Conclusions:
The concentration of plasma Lp-PLA2 in patients with CHD was higher than that in the control group. The concentration of plasma Lp-PLA2 in the subgroups of CHD patients varied greatly from each other. The inflammatory response of atherosclerosis might be resulted from the synergy of plasma Lp-PLA2 and hs-CRP.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction

